Literature DB >> 20666401

Evaluation of copper-64 labeled AmBaSar conjugated cyclic RGD peptide for improved microPET imaging of integrin alphavbeta3 expression.

Hancheng Cai1, Zibo Li, Chiun-Wei Huang, Anthony H Shahinian, Hui Wang, Ryan Park, Peter S Conti.   

Abstract

Recently, we have developed a new cage-like bifunctional chelator 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo [6.6.6] icosane-1-ylamino) methyl) benzoic acid (AmBaSar) for copper-64 labeling and synthesized the positron emission tomography (PET) tracer (64)Cu-AmBaSar-RGD. In this study, we further evaluate the biological property of this new AmBaSar chelator by using (64)Cu-AmBaSar-RGD as the model compound. In vitro and in vivo stability, lipophilicity, cell binding and uptake, microPET imaging, receptor blocking experiments, and biodistribution studies of (64)Cu-AmBaSar-RGD were investigated, and the results were directly compared with the established radiotracer (64)Cu-DOTA-RGD. The (64)Cu-AmBaSar-RGD was obtained with high radiochemical yield (> or =95%) and purity (> or =99%) under mild conditions (pH 5.0-5.5 and 23-37 degrees C) in less than 30 min. For in vitro studies, the radiochemical purity of (64)Cu-AmBaSar-RGD was more than 97% in PBS or FBS and 95% in mouse serum after 24 h of incubation. The log P value of (64)Cu-AmBaSar-RGD was -2.44 +/- 0.12. For in vivo studies, (64)Cu-AmBaSar-RGD and (64)Cu-DOTA-RGD have demonstrated comparable tumor uptake at selected time points on the basis of microPET imaging. The integrin alpha(v)beta(3) receptor specificity was confirmed by blocking experiments for both tracers. Compared with (64)Cu-DOTA-RGD, (64)Cu-AmBaSar-RGD demonstrated much lower liver accumulation in both microPET imaging and biodistribution studies. Metabolic studies also directly supported the observation that (64)Cu-AmBaSar-RGD was more stable in vivo than (64)Cu-DOTA-RGD. In summary, the in vitro and in vivo evaluations of the (64)Cu-AmBaSar-RGD have demonstrated its improved Cu-chelation stability compared with that of the established tracer (64)Cu-DOTA-RGD. The AmBaSar chelator will also have general applications for (64)Cu labeling of various bioactive molecules in high radiochemical yield and high in vivo stability.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20666401     DOI: 10.1021/bc900537f

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  24 in total

1.  Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability.

Authors:  Maggie S Cooper; Michelle T Ma; Kavitha Sunassee; Karen P Shaw; Jennifer D Williams; Rowena L Paul; Paul S Donnelly; Philip J Blower
Journal:  Bioconjug Chem       Date:  2012-04-13       Impact factor: 4.774

2.  Efficient preparation and biological evaluation of a novel multivalency bifunctional chelator for 64Cu radiopharmaceuticals.

Authors:  Shuanglong Liu; Zibo Li; Li-Peng Yap; Chiun-Wei Huang; Ryan Park; Peter S Conti
Journal:  Chemistry       Date:  2011-08-04       Impact factor: 5.236

3.  Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals.

Authors:  Sibaprasad Bhattacharyya; Manish Dixit
Journal:  Dalton Trans       Date:  2011-05-03       Impact factor: 4.390

4.  Design, synthesis and validation of integrin α2β1-targeted probe for microPET imaging of prostate cancer.

Authors:  Chiun-Wei Huang; Zibo Li; Hancheng Cai; Kai Chen; Tony Shahinian; Peter S Conti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-25       Impact factor: 9.236

5.  Evaluation of 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculature.

Authors:  Kai Chen; Xilin Sun; Gang Niu; Ying Ma; Li-Peng Yap; Xiaoli Hui; Kaichun Wu; Daiming Fan; Peter S Conti; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2012-02       Impact factor: 3.488

6.  Synthesis and radiolabeling of chelator-RNA aptamer bioconjugates with copper-64 for targeted molecular imaging.

Authors:  William M Rockey; Ling Huang; Kyle C Kloepping; Nicholas J Baumhover; Paloma H Giangrande; Michael K Schultz
Journal:  Bioorg Med Chem       Date:  2011-05-14       Impact factor: 3.641

7.  Efficient construction of PET/fluorescence probe based on sarcophagine cage: an opportunity to integrate diagnosis with treatment.

Authors:  Shuanglong Liu; Dan Li; Chiun-Wei Huang; Li-Peng Yap; Ryan Park; Hong Shan; Zibo Li; Peter S Conti
Journal:  Mol Imaging Biol       Date:  2012-12       Impact factor: 3.488

Review 8.  Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.

Authors:  Zhiyong Wang; Gang Liu; Hairong Zheng; Xiaoyuan Chen
Journal:  Biotechnol Adv       Date:  2013-09-05       Impact factor: 14.227

Review 9.  The growing impact of bioorthogonal click chemistry on the development of radiopharmaceuticals.

Authors:  Dexing Zeng; Brian M Zeglis; Jason S Lewis; Carolyn J Anderson
Journal:  J Nucl Med       Date:  2013-04-24       Impact factor: 10.057

10.  Pycup--a bifunctional, cage-like ligand for (64)Cu radiolabeling.

Authors:  Eszter Boros; Elena Rybak-Akimova; Jason P Holland; Tyson Rietz; Nicholas Rotile; Francesco Blasi; Helen Day; Reza Latifi; Peter Caravan
Journal:  Mol Pharm       Date:  2013-12-11       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.